Brief: Cumberland To Expand Availability Of Caldolor For High Fever Associated With Coronavirus
31/03/2020 22:47
March 31 (Reuters) - Cumberland Pharmaceuticals Inc
CPIX.O :
* CUMBERLAND PHARMACEUTICALS ANNOUNCES INITIATIVE TO EXPAND
AVAILABILITY OF CALDOLOR® TO HELP TREAT HIGH FEVERS ASSOCIATED
WITH CORONAVIRUS INFECTIONS
* CUMBERLAND PHARMACEUTICALS - INITIATIVE INCLUDES
AVAILABILITY OF
SPECIAL SUPPLY AND FINANCIAL ARRANGEMENTS
Source text for Eikon: ID:nPnY2lKDa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM